CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company specializing in mRNA-based therapies and vaccines with a market ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...

The global APOL1-mediated kidney disease market is poised for substantial expansion, with projections indicating a remarkable ...

When something is working extremely well, we should demand very compelling evidence before changing it. I believe that’s why ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Aspercreme's first major campaign in four years shows boomers "authentically defying outdated perceptions of aging," says parent brand CMO.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...